Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

William J Liu

18PUBLICATIONS

38CO-AUTHORS

Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityAgricultural molecular engineering of nucleic acids and proteinsFish pests and diseases

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Mar 12, 2025

Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.

Peiwen Qiao, Can Yue, Weiyu Peng

|Jan 28, 2025

T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots.

Jinmin Tian, Bingli Shang, Jianing Zhang

|Jun 17, 2024

Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations.

Ting Zhang, Yang Han, Weijuan Huang

|Jun 12, 2024

Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents.

Xin Wang, Jie Zhang, Maoshun Liu

|Jan 03, 2024

Characterization of CD8<sup>+</sup> T cells in immune-privileged organs of ZIKV-infected <i>Ifnar1</i><sup>-/-</sup> mice.

Hangjie Zhang, Wenling Xiao, Min Zhao

|Aug 07, 2023

Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents.

Maoshun Liu, Jie Zhang, Lei Li

Pageof 3

Frequent Collaborators

13 joint publications

George F Gao

3 joint publications

Jianxun Qi

2 joint publications

Weifeng Shi

2 joint publications

Yi Shi

2 joint publications

Yuhai Bi

1 joint publications

Guizhen Wu

1 joint publications

Rong Chen

1 joint publications

Junya Wang

1 joint publications

Chun Xia

1 joint publications

Hangjie Zhang

Frequent Collaborators

13 joint publications

George F Gao

3 joint publications

Jianxun Qi

2 joint publications

Weifeng Shi

2 joint publications

Yi Shi

Top Related Videos

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on : Jan 09, 2019

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos

Top Related Videos

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation

Published on : Jan 09, 2019

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos